Sort by
Refine Your Search
-
Country
-
Employer
- Stanford University
- Institute for bioengineering of Catalonia, IBEC
- Yale University
- Cornell University
- EPFL
- The University of Arizona
- Aalborg University
- CNRS
- Delft University of Technology (TU Delft)
- Duke University
- Ghent University
- King's College London
- NEW YORK UNIVERSITY ABU DHABI
- National Institute of Research and Innovation
- Rutgers University
- Technical University of Munich
- University of Maryland, Baltimore
- University of Miami
- University of North Carolina at Chapel Hill
- University of Oxford
- Argonne
- CY Cergy Paris Université
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Chalmers University of Technology
- Durham University
- FCiências.ID
- Florida Gulf Coast University
- Fundació per a la Universitat Oberta de Catalunya
- Harvard University
- Heidelberg University
- ICN2
- Imperial College London
- Karolinska Institutet (KI)
- Massachusetts Institute of Technology
- Massachusetts Institute of Technology (MIT)
- McGill University
- Northeastern University
- Oak Ridge National Laboratory
- Pennsylvania State University
- Queen Mary University of London
- Queen Mary University of London;
- Research Center for Molecular Medicine (CeMM), ÖAW
- SUNY University at Buffalo
- Stony Brook University
- The University of Queensland
- Universidade de Coimbra
- University of Amsterdam (UvA)
- University of Central Florida
- University of Colorado
- University of Liverpool
- University of Lund
- University of Nebraska Medical Center
- University of New Hampshire
- University of Oregon
- University of Pittsburgh
- University of Sydney
- University of Tartu
- University of Texas at Arlington
- University of Washington
- Vrije Universiteit Brussel (VUB)
- 50 more »
- « less
-
Field
-
of therapeutic targets and novel anticancer agents for endocrine cancers. Required Qualifications: • PhD in cancer biology, cell biology, molecular biology, bioengineering, or a closely related field
-
for highly motivated postdoctoral candidates with a PhD in bioengineering deep knowledge in computational biology and machine learning. Candidates with a molecular biology or engineering degrees with
-
We welcome applicants with a PhD in neuroscience, cancer biology, cell biology, molecular biology, bioengineering, or a related field, together with excellent written and spoken English skills. We
-
EUR 52 000,- p.a. before tax Health insurance Dedicated funding for training and short-term mobility, subject to project arrangements. Eligibility We are searching for the candidate with: PhD in a
-
(Germany). Benefits Basic salary EUR 52 000,- p.a. before tax Health insurance Dedicated funding for training and mobility Eligibility We are searching for the candidate with: PhD in Chemistry, Materials
-
a postdoc presupposes scientific qualifications at PhD level within genetic engineering and molecular biology combined with a focus on innovation and commercialization. The successful applicant is
-
CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences | Austria | 2 months ago
potential to receive an ERC Starting Grant in the future; Open to both PhD (natural sciences) and MD (medical sciences) holders; From a variety of academic backgrounds: molecular biology, biomedical research
-
sciences Biological sciences » Biological engineering Researcher Profile Recognised Researcher (R2) Positions PhD Positions Application Deadline 15 Sep 2026 - 23:59 (Europe/Lisbon) Country Portugal Type
-
experimental data. Minimum Qualifications PhD in biomedical engineering, neuroscience, electrical engineering, medical physics, bioengineering, or a closely related field upon hire. Preferred Qualifications FLSA
-
Australian Institute for Bioengineering and Nanotechnology Full-time (100%), fixed-term position for up to 2 years Base salary will be in the range $85,372.89 - $113,659.72 + 17% super (Academic